Effects of Acarbose in Metabolic Control of Patients with Type 1 Diabetes Mellitus

How to Cite:Sharifi F, Ghazi Saidi M, Mousavi Nasab N. Effects of Acarbose in Metabolic Control of Patients with Type 1 Diabetes Mellitus. Int J Endocrinol Metab. 2008;6(1):. doi:

Abstract

A carbose is a reversible inhibitor of the intestinal alpha-glucosidases, the oral administration of which delays absorption of carbohydrates. The aim of this study was to investigate the effect of administration of acarbose on parameters of gly-caemic control, lipid parameters and tolerability in ambulant type 1 diabetic subjects. Materials and Methods: Entry criteria included being: diabetic, age below 30 years and a history of at least one episode of diabetic ketoacidosis insufficiently controlled with diet and insulin. The data of 17 patients (6 men and 11 women, mean age 17.2±3.5 (range 14–26) years, median duration of diabetes 8 (range 1–20) years were valid for statistical analysis. Results: During the run-in period HbA1c levels tended to decrease from 9.5±1.1 to 9±1.7%. After 12 weeks of acarbose treatment, the mean level had decreased further to 7.6±1.6% (P: 0.002). Af-ter discontionuing acarbose, HbA1c levels in-creased to a mean level of 8.8±0.9%. A significant reduction in Fasting Plasma Glucose (FPG) (from 195±62 to 139±73 mg/dL, P<0.01) and 2 hour post prandial glucose (2 hppG) was observed with acarbose (from 231±82 to 159±72 mg/dL, P<0.001). Reduction in total cholesterol (from 159±36 to 146±26 mg/dL, p: 0.09) and triglycerides (from100±22 to 81±23 mg/dL, p: 0.02) was de-tected after treatment with acarbose. No signifi-cant changes were observed in HDL cholesterol. The most frequent reported adverse events were flatulence (7 subjects) and mild abdominal pain (2 subjects). Conclusion: We conclude that acarbose up to 3×100 mg/day can be a valuable adjunct to insu-lin in improving metabolic control in persons with type 1 diabetes

Keywords

Type 1 diabetes

Glycemic control

Acarbose

Alpha glucosidase inhibitors

Full Text

Full text is available in PDF

Import into EndNote Import into BibTex

Share on

Comments

Number of Comments:0

Cited by

Scopus by DOI: 0
Last Update: 6 days ago
Scopus by Title: 0
Last Update: 6 days ago
Scopus by Title (Ref): 2
Last Update: 6 days ago
CrossRef: 0
Last Update: 4 days ago

Metrics

Ordering Reprints

Articles are published under the Creative Commons license stated on each article. No permission or royalty fee is required for uses permitted by that license. CCC handles optional bulk and customized reprint orders. Any quotation covers production and delivery services only, not copyright permission. > Request Reprints from CCC

Search Relations

Author(s):

F Sharifi:[PubMed][Scholar]
M Ghazi Saidi:[PubMed][Scholar]
N Mousavi Nasab:[PubMed][Scholar]

Research Institute for Endocrine Sciences

Outlines

Effects of Acarbose in Metabolic Control of Patients with Type 1 Diabetes Mellitus

Abstract

Full Text

Last Update: 6 days ago

Last Update: 6 days ago

Last Update: 6 days ago

Last Update: 4 days ago